Thyroid Cancer
News
Motesanib Diphosphate Provides Anticancer Activity Among Patients with Progressive Thyroid Cancer
(07/03/2008)
The investigative agent motesanib diphosphate (AMG 706) produces a regression of cancer among patients with thyroid cancer that is progressing despite standard therapies. These results were recently published in the New England Journal of Medicine.
Differences in IMRT Radiation Doses May Complicate Study Results in Thyroid Cancer
(03/28/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in thyroid cancer difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Being Overweight Associated with Increased Risk of Several Cancers
(02/19/2008)
Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet.
PET/CT Scans Assist in Diagnosis of Recurrent Thyroid Cancer
(02/15/2007)
Researchers from the U.K. have reported that imaging with a combination of positron emission tomography (PET) and computed tomography (CT) can detect recurrent or metastatic thyroid cancer in patients who have an elevated thyroglobulin level and a negative (131)I whole-body scintigraphy examination (WBS). These results were published in the Journal of Nuclear Medicine.
Chornobyl Survivors Experience Increase in Thyroid Cancer
(07/11/2006)
According to a study of Ukrainians who were under the age of 18 at the time of the Chornobyl accident, risk of thyroid cancer increased with increasing levels of radiation exposure. These results were published in the Journal of the National Cancer Institute.
More
Thyroid Cancer
Cancer News...